supported by Fundamental Research Funds for the Central Universities (2662021SCPY006);National Key Research and Development Program of China (2018YFD0900504).
Herpesviral hematopoietic necrosis disease caused by cyprinid herpesvirus 2(CyHV-2)results in huge economic losses for the gibel carp(Carassius auratus gibelio)aquaculture industry.A vaccination strategy is a feasible...
Ministry of Science and Technology of China,Grant/Award Number:2022YFE0110200;Natural Science Foundation of Jilin Province,Grant/Award Number:20230101037JC;National Natural Science Foundation of China,Grant/Award Numbers:52203198,52025035。
Ultrasound-generated antigens combined with TLR7/8 agonists as adjuvants have demonstrated significant anti-tumor efficacy as an in-situ vaccine.However,the use of TLR7/8 agonists can cause severe inflammatory respons...
This review aims to summarize the currently viable vaccine strategies including the approved vaccines and the those in trials for next-generation malaria vaccines.Data on malaria vaccine development was collected thro...
research funding from Guangzhou Women and Children Medical Center,the National Key Research and Development Program of China(2018YFA0107200);National Natural Science Foundation of China(81730005 and 31771616);Macao FDCT(FDCT 0106/2021/A)。
Dear Editor,Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is an enveloped positive-sense single-stranded RNA(ssRNA)virus responsible for the global COVID-19 pandemic.Although vaccines for SARS-CoV-2 have ...
the National Key Research and Development Program of China(Nos.2022YFC2603500/2022YFC2603501 and 2021YFC2400600/2021YFC2400603/2021YFC2400604);the National Natural Science Foundation of China(Nos.52273158,U21A2099,52022095,51973216,and 51873207);the Science and Technology Development Program of Jilin Province(Nos.20220204018YY,20210509005RQ,20210504001GH,and 20200404182YY);the Youth Innovation Promotion Association of Chinese Academy of Sciences(No.2019230);the Special Project for City–Academy Scientific and Technological Innovation Cooperation of Changchun(No.21SH14);the Fundamental Research Funds for the Central Universities,JLU.
Infectious diseases are severe public health events that threaten global health.Prophylactic vaccines have been considered as the most effective strategy to train the immune system to recognize and clear pathogenic in...
the support from the Medical and Health Science and Technology Program of Zhejiang Province,China(No.2020379356);the China Postdoctoral Science Foundation(No.2020T130102ZX)。
Repeated waves of influenza virus H7N9 epidemics after 2013 have caused severe influenza in humans,with mortality reaching approximately 40%–50%.To prevent possible pandemics,the development of highly effective vacci...
New adjuvants that potently improve vaccine efficacy with extremely low toxicity are urgently needed.In a recent study in Cell Research,Liu et al.show that a new STING agonist CF501 facilitates a SARS-CoV-2 subunit va...
support of National Key Research and Development Program of China(2021YFE0103100,China);National Natural Science Foundation of China of China(81925035,81673382,and 81521005,China);National Special Project for Significant New Drugs Development(2018ZX09711002-010-002,China);Shanghai SciTech Innovation Initiative(19431903100,18430740800,China);Shanghai Collaborative Innovation Group of Early Diagnosis and Precise Treatment of Hemangiomas and Vascular Malformations(SSMU-ZDCX20180701,China);Chinese Pharmaceutical Association-Yiling Pharm Joint Grants(CPAYLJ201901,China)for the support。
An essential step for cancer vaccination is to break the immunosuppression and elicit a tumor-specific immunity.A major hurdle against cancer therapeutic vaccination is the insufficient immune stimulation of the cance...
This work was supported by the National Key Research and Development Program of China(No.2016YFA0201402);National Natural Science Foundation Regional Innovation and Development(U19A2003);The National Major Scientific and Technological Special Project for“Significant New Drugs Development”(No.2018ZX09733001).
Dear Editor,The worldwide outbreak of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection has urged the investigation of preventive vaccines.Recently,our team has developed a recombinant protein vacci...
Research grant from the Office of Higher Education Commission via Chulalongkorn University,the fiscal year 2014–2015 is acknowledged。
Squalene-based oil-in-water(O/W)emulsions have been used as effective and safe adjuvants in approved influenza vaccines.However,there are concerns regarding the safety and side effects of increasing risk of narcolepsy...